PABPN1 and oculopharyngeal muscular dystrophy: Taken together, these data suggest that at 6 months of age, Pabpn1+/A17 mice exhibit weak dysphagia, which is consistent with the dysphagia experienced by humans at the onset of OPMD but the effect is lost with age.